HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tooth Attrition D019217 1 associated lipids
HIV Enteropathy D019053 1 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Vascular Neoplasms D019043 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Nevus, Epithelioid and Spindle Cell D018332 1 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Cystadenocarcinoma, Papillary D018283 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Aoki M et al. Expression of BMP-7 in human gastric cancer and its clinical significance. 2011 Br. J. Cancer pmid:21224856
Maeda S et al. Clinical significance of midkine expression in pancreatic head carcinoma. 2007 Br. J. Cancer pmid:17622248
Hsieh JL et al. Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5. 2003 Br. J. Cancer pmid:12778082
Liu WM et al. Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). 2009 Br. J. Cancer pmid:19638977
Terry G et al. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. 2004 Br. J. Cancer pmid:15570308
Mellado B et al. Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. 2009 Br. J. Cancer pmid:19755998
Couvelard A et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. 2005 Br. J. Cancer pmid:15558070
Kupryjańczyk J et al. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. 2003 Br. J. Cancer pmid:12644821
Shetty G et al. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. 2006 Br. J. Cancer pmid:16622450
Scott IS et al. A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. 2006 Br. J. Cancer pmid:16622441
Eichenmüller M et al. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. 2010 Br. J. Cancer pmid:20517313
Brownhill SC et al. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. 2007 Br. J. Cancer pmid:17533400
Buggy Y et al. Overexpression of the Ets-1 transcription factor in human breast cancer. 2004 Br. J. Cancer pmid:15365563
Unoki M et al. UHRF1 is a novel diagnostic marker of lung cancer. 2010 Br. J. Cancer pmid:20517312
Millar EK et al. BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. 2009 Br. J. Cancer pmid:19066611
Pamecha V et al. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. 2009 Br. J. Cancer pmid:19209170
Aoyagi Y et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. 2004 Br. J. Cancer pmid:15365564
Li Q et al. Expression of interferon-gamma in human adrenal gland and kidney tumours. 2007 Br. J. Cancer pmid:17622250
Clark SE et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. 2011 Br. J. Cancer pmid:21139586
Takano T et al. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. 2007 Br. J. Cancer pmid:17453004
Weinlich G et al. Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. 2006 Br. J. Cancer pmid:16508630
Grunewald TG et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. 2007 Br. J. Cancer pmid:17211471
Fareed KR et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. 2010 Br. J. Cancer pmid:20461087
Frietsch JJ et al. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. 2010 Br. J. Cancer pmid:20461080
Bibi R et al. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. 2006 Br. J. Cancer pmid:17031402
Bruland O et al. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. 2008 Br. J. Cancer pmid:18349847
Yoshioka T et al. Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18349839
Sakamoto A et al. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. 2004 Br. J. Cancer pmid:15266333
Puppa G et al. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. 2007 Br. J. Cancer pmid:17375048
Schmitz M et al. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. 2007 Br. J. Cancer pmid:17375044
Comstock CE et al. Impact of differential cyclin D1 expression and localisation in prostate cancer. 2007 Br. J. Cancer pmid:17375037
Kazama S et al. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. 2006 Br. J. Cancer pmid:16404429
Arnould L et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? 2006 Br. J. Cancer pmid:16404427
Went P et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. 2006 Br. J. Cancer pmid:16404366
Bingle L et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. 2006 Br. J. Cancer pmid:16404363
Zheng BY et al. Detection of adeno-associated virus type 2 genome in cervical carcinoma. 2006 Br. J. Cancer pmid:16736006
Koljonen V et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. 2009 Br. J. Cancer pmid:19755994
Shehata M et al. Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. 2009 Br. J. Cancer pmid:19755991
Lugli A et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. 2009 Br. J. Cancer pmid:19755986
Angst E et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. 2006 Br. J. Cancer pmid:16832411
Sheridan J et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. 2009 Br. J. Cancer pmid:19066606
Ameri K et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. 2010 Br. J. Cancer pmid:20051957
Sigstad E et al. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. 2002 Br. J. Cancer pmid:12107839
Fenton BM et al. Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis. 2002 Br. J. Cancer pmid:12087474
Brown NJ et al. Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. 2002 Br. J. Cancer pmid:12087471
Clemons MJ et al. Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours. 2002 Br. J. Cancer pmid:12087469
Pazgal I et al. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. 2002 Br. J. Cancer pmid:12087465
Bhagavathula N et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. 2005 Br. J. Cancer pmid:16278666
Chou SC et al. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. 2004 Br. J. Cancer pmid:14760391
Sasiadek MM et al. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. 2004 Br. J. Cancer pmid:15083191
Reitsamer R et al. 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up. 2004 Br. J. Cancer pmid:15083184
Weigelt B et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. 2004 Br. J. Cancer pmid:15083181
Olivier RI et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. 2004 Br. J. Cancer pmid:15083174
Shinto O et al. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. 2010 Br. J. Cancer pmid:20145621
Otake M et al. Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma. 2003 Br. J. Cancer pmid:12915887
Hussain SA et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. 2007 Br. J. Cancer pmid:17213826
Hosono S et al. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. 2007 Br. J. Cancer pmid:17211477
Takemoto S et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. 2009 Br. J. Cancer pmid:19638983
Mitra A et al. Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. 2008 Br. J. Cancer pmid:18182994
Ash S et al. Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation. 2010 Br. J. Cancer pmid:20978501
Prowatke I et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. 2007 Br. J. Cancer pmid:17146477
Hamaguchi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. 2005 Br. J. Cancer pmid:15785749
Mizukami Y et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. 2008 Br. J. Cancer pmid:18087278
Kostourou V et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. 2011 Br. J. Cancer pmid:21139581
Franc B et al. Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine. 2003 Br. J. Cancer pmid:14647144
Wu CF et al. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract. 2010 Br. J. Cancer pmid:20736946
Rachagani S et al. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. 2011 Br. J. Cancer pmid:21364589
Cui T et al. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. 2011 Br. J. Cancer pmid:21364582
Verschoyle RD et al. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. 2007 Br. J. Cancer pmid:17211473
Knijn N et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. 2011 Br. J. Cancer pmid:21364579
Cocco E et al. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. 2009 Br. J. Cancer pmid:19536090
Farooqui M et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. 2007 Br. J. Cancer pmid:17971769
Donnelly ET et al. Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. 2005 Br. J. Cancer pmid:15928667
Ord JJ et al. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma. 2005 Br. J. Cancer pmid:15928663
Milde-Langosch K et al. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. 2005 Br. J. Cancer pmid:15928662
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Staibano S et al. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. 2007 Br. J. Cancer pmid:17987038
Ma S et al. O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. 2003 Br. J. Cancer pmid:14562026
Mellor P et al. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. 2007 Br. J. Cancer pmid:17726466
Yamamoto E et al. Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. 2007 Br. J. Cancer pmid:17971775
Debrock G et al. A phase II trial with rosiglitazone in liposarcoma patients. 2003 Br. J. Cancer pmid:14562008
Al-Attar A et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. 2010 Br. J. Cancer pmid:20087352
Larsson A et al. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. 2011 Br. J. Cancer pmid:21829192
Weng WH et al. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. 2003 Br. J. Cancer pmid:12915885
Nosho K et al. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. 2005 Br. J. Cancer pmid:15785755
Matsumoto N et al. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. 2003 Br. J. Cancer pmid:12915883
Ajisaka H and Miwa K Micrometastases in sentinel nodes of gastric cancer. 2003 Br. J. Cancer pmid:12915877
MacGrogan G et al. DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. 2003 Br. J. Cancer pmid:12915875
Dive C et al. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. 2010 Br. J. Cancer pmid:20051949
Alazawi W et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. 2004 Br. J. Cancer pmid:15545968
Nomura H et al. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. 2007 Br. J. Cancer pmid:17726464
Sersa G et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. 2008 Br. J. Cancer pmid:18182988
Horii R et al. Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. 2007 Br. J. Cancer pmid:17726451
de Graeff P et al. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. 2008 Br. J. Cancer pmid:18628764
Jekimovs CR et al. Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. 2005 Br. J. Cancer pmid:15700044
te Velde EA et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. 2005 Br. J. Cancer pmid:15700042
Roka F et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. 2005 Br. J. Cancer pmid:15700039
Gerber SA et al. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. 2003 Br. J. Cancer pmid:12778077
Wagenaar-Miller RA et al. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. 2003 Br. J. Cancer pmid:12778076
Tonetti DA et al. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. 2003 Br. J. Cancer pmid:12778068